Status:
COMPLETED
Heart Aging When Near Vision Difficulty Begins
Lead Sponsor:
Kecioren Education and Training Hospital
Conditions:
Aging
Eligibility:
All Genders
49-51 years
Brief Summary
Near vision deterioration during aging results from a decrease in accomodation amplitude (AA). Myocardial regeneration is limited, and cardiac aging is an independent risk factor for cardiovascular di...
Detailed Description
Lens cells and proteins are encapsulated, and they are not turned over or replaced.The lens nucleus starts to form before birth, so the nucleus is one of the three oldest tissues in the body .With agi...
Eligibility Criteria
Inclusion
- Healthy Volunteers, mean 50 years of age (49-51)
Exclusion
- Hypertension, Diabetes mellitus, Atrial fibrillation, Coronary artery disease, Arrhythmia, Hyperthyroidism , Anemia, Heart failure, Respiratory diseases, Severe obesity (body mass index ≥35 kg/m2),
Key Trial Info
Start Date :
September 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04362215
Start Date
September 10 2019
End Date
March 15 2020
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ANkara Keçiören EAH
Ankara, Turkey (Türkiye), 06530